Methods for suppressing myeloid cells with chemokines
Patent Number: 6165459
Date of First Priority Issue: Wednesday December 9th, 1992
Date Issued: Tuesday December 26th, 2000
Assignee: Indiana University Foundation (Indianapolis, IN)
Inventors: Broxmeyer, Hal E. (Indianapolis, IN); Cooper, Scott (Indianapolis, IN); Mantel, Charles (Indianapolis, IN); Lu, Li (Indianapolis, IN)
From Class: Expansion
Comments: No comments
This patent teaches that administration of various chemokines, such as, for example MIP-1 alpha or IL-8, inhibits the production of myeloid stem cell derived cells such as granulocytes or monocytes.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.